SCHEDULE: Farallon Capital Discloses 5.1% Stake in Lantheus

Farallon Capital and its affiliates have filed an amended Schedule 13G, reporting a collective beneficial ownership of 5.1% of Lantheus Holdings, Inc.'s common stock as of September 30, 2025.

Summary

• Farallon Capital and its affiliated entities and individuals (collectively, the "Reporting Persons") have filed an Amendment No. 3 to Schedule 13G concerning their beneficial ownership of common stock in Lantheus Holdings, Inc.
• Farallon Partners, L.L.C. beneficially owns 3,381,580 shares, representing 5% of the class of common stock.
• Each of the Farallon Individual Reporting Persons (managing members/senior managing members) beneficially owns 3,477,227 shares, representing 5.1% of the class of common stock.
• All reported shares are held with shared voting power and shared dispositive power.
• The Reporting Persons certify that the securities were not acquired or held for the purpose of changing or influencing control of the issuer, except for activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 6

Explanation: The filing indicates a significant, passive institutional stake by Farallon Capital, which can be viewed as a positive signal of confidence in Lantheus Holdings. However, it is purely an ownership disclosure and does not contain operational or financial performance data to assess sentiment more broadly.

Positives

• A significant institutional investor, Farallon Capital, maintains a substantial stake in Lantheus Holdings, Inc., which can signal confidence in the company.
• The filing explicitly states the shares were not acquired for the purpose of changing or influencing control, suggesting a passive investment approach, which may reduce concerns about activist pressure.

Negatives

• The filing does not contain any negative operational or financial information about Lantheus Holdings, Inc.

Risks

• The filing itself does not detail risks related to Lantheus Holdings, Inc.'s operations or financial health, as it is an ownership disclosure.

Future Outlook

The filing is an ownership disclosure and does not provide forward-looking statements or guidance regarding Lantheus Holdings, Inc.'s future performance or strategic direction.

Management Comments

• The filing does not contain direct quotes or paraphrased statements from Lantheus Holdings, Inc. management. It includes a certification from Farallon Capital's managing member regarding the purpose of the investment.

Industry Context

This filing indicates a notable institutional investment in Lantheus Holdings, Inc., a company operating in the healthcare sector. Such disclosures are common for large investment firms taking significant, passive stakes in publicly traded companies, reflecting their portfolio allocation strategies rather than specific industry trends.

Comparison to Industry Standards

• This filing is a standard Schedule 13G amendment, reporting beneficial ownership. It does not contain information that allows for a direct comparison of Lantheus Holdings, Inc.'s operational or financial results against industry benchmarks or specific comparable companies or projects.

Management Changes

Corporate Governance

Legal Proceedings

• The filing does not mention any litigation or regulatory matters concerning Lantheus Holdings, Inc. or the Reporting Persons.

Related Party Transactions

• The filing does not disclose any related party dealings.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional investor's stake may provide a level of confidence or stability, potentially influencing market perception.
• Company Management: Awareness of a large, passive institutional holder may influence strategic decisions, though the filing explicitly disclaims intent to influence control, except for director nominations.

Next Steps

• The filing does not mention any specific future actions, events, or milestones for Lantheus Holdings, Inc. or the Reporting Persons beyond the ongoing passive investment.

Key Dates

Recommendation

This Schedule 13G filing is a routine disclosure of beneficial ownership by a passive institutional investor, Farallon Capital, and its affiliates. It indicates a continued significant stake (5.1%) in Lantheus Holdings, Inc. While the presence of a large institutional investor can be a positive signal, the filing itself provides no new operational, financial, or strategic information about Lantheus Holdings, Inc. that would warrant a change in investment recommendation. The stated passive intent of the investment, with the allowance for director nominations, further supports a 'hold' recommendation, as there's no indication of impending corporate action or significant change in company direction driven by this shareholder.

Keywords

Lantheus Holdings, Farallon Capital, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Equity Stake, SEC Filing, Passive Investment, Healthcare